Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

M&A/IPOs

 

Everstone Capital invests $270 million in Apothecon Group

Singapore-based private equity firm Everstone Capital has invested around $270 million in Apothecon Group, a specialty pharma Contract Development and Manufacturing Organisation (CDMO). The combined group includes India-based Apothecon and US-based Navinta. Together, they work on complex molecules, mainly in iron and peptide-based chemistry.
April 23, 2026

Nord Holding buys stake in VisionmaxX Group

Private equity firm Nord Holding has acquired a majority stake in the VisionmaxX Group, a German healthcare IT service provider. VisionmaxX provides IT services, including IT infrastructure, telematics, IT security, and digital practice solutions for German and Austrian dental practices, orthodontists, and oral and maxillofacial surgeons.
April 20, 2026

Polypeptide Group attracts takeover interest from private equity firms

Polypeptide Group, a contract development and manufacturing organisation (CDMO) serving pharmaceutical and biotech companies, has attracted takeover interest from private equity investors. The company specialises in peptide-based active pharmaceutical ingredients (APIs) and operates manufacturing sites across the United States, Europe, and India.
April 16, 2026

H.I.G. Capital-backed Vernacare buys Eakin Surgical

Vernacare, a manufacturer of single-use medical devices and healthcare consumables backed by private equity firm H.I.G. Capital has acquired Eakin Surgical Limited from Eakin Healthcare Group, a family-owned medical device company. Eakin Surgical is a UK-based manufacturer of single-use surgical instruments.
April 16, 2026

Rantum Capital acquires German medtech firm Tontarra 

Frankfurt-based investment firm Rantum Capital has acquired Tontarra Medizintechnik GmbH, a German developer and manufacturer of high-precision, premium surgical instruments and endoscopy products. This is the seventh investment from Rantum Capital’s mid-market private equity investment vehicle, Rantum Private Equity Fund II, which focuses on the DACH region. 
April 9, 2026

Healthbridge buys AI scribe Nora

Healthbridge, a South African health technology company, has acquired Nora, a London-based AI medical scribe. With this acquisition, it will now embed Nora’s AI capabilities directly into its clinical platform.
April 9, 2026

LDC exits PAM Healthcare for £100 million

Private equity investment firm LDC has completed the exit of occupational health services provider PAM Healthcare to the UK’s largest pure play occupational health provider by revenue, Optima Health, for £100 million.
April 2, 2026
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us